Learn how a large, multi site study supports laboratory adoption of extragenital CT/NG testing on an automated, high throughput platform. We’ll review study design (remnant specimens; composite ...
LANSING, Mich., July 15, 2020 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today that it has launched an advanced test system that automatically detects microorganisms in a fraction of ...
SANTA MARIA, Calif., July 29, 2025 /PRNewswire/ -- Hardy Diagnostics is pleased to announce the FDA clearance of the NG-TEST® CTX-M Multi, an in vitro, rapid, and visual immunoassay for the ...
CHICAGO, July 4, 2023 /PRNewswire/ -- In the near future, the CT/NG (Chlamydia and Gonorrhea) testing industry is poised to witness significant advancements and transformations. With the increasing ...
Learn how a large, multi-site study supports laboratory adoption of extragenital CT/NG testing on an automated, high throughput platform. This episode reviews importance of extragenital sample ...
Male urine and self-collected vaginal swabs are the preferred specimen types for CT and NG testing, according to the summary report from the U.S. Association of Public Health Laboratories and Centers ...
Xpert CT/NG Test for Chlamydia and Gonorrhea Approved Cepheid announced that it has received clearance from the FDA to market Xpert CT/NG, an in vitro molecular diagnostic test for the detection and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results